Browse > Article
http://dx.doi.org/10.15204/jkobgy.2013.26.2.017

A Study on the Inhibitory Effect and Mechanism of Lonicera Japonica on Type I Interferon  

Kang, Yong-Goo (Dept. of Oriental Obstetrics & Gynecology, College of Oriental Medicine, Won-Kwang University)
Ryu, Ik-Han (Dept. of Oriental Obstetrics & Gynecology, College of Oriental Medicine, Won-Kwang University)
Kim, Song-Baek (Dept. of Oriental Obstetrics & Gynecology, College of Oriental Medicine, Won-Kwang University)
Choi, Chang-Min (Dept. of Oriental Obstetrics & Gynecology, College of Oriental Medicine, Won-Kwang University)
Seo, Yun-Jung (Dept. of Oriental Obstetrics & Gynecology, College of Oriental Medicine, Won-Kwang University)
Cho, Han-Baek (Dept. of Oriental Obstetrics & Gynecology, College of Oriental Medicine, Won-Kwang University)
Publication Information
The Journal of Korean Obstetrics and Gynecology / v.26, no.2, 2013 , pp. 17-32 More about this Journal
Abstract
Objectives: The purpose of this study was to investigate whether Lonicera japonica(LJ) could inhibit LPS-induced type I IFN production. Methods: To evaluate inhibitory effect of LJ on type I IFN, we examined type I IFN, IRF-1, 7 and IL-10 production on LPS-induced macrophages using real time RT-PCR. Next, we observed the interaction of type I IFN, IRF-1, 7 and IL-10 using IL-10 neutralizing antibody. Finally we examined the activation of STAT-1, 3 using western blot. Results: LJ inhibited Type I IFN expression of mRNA and increased IL-10 expression of mRNA. Also LJ inhibited the level of IRF-1, 7 mRNA and the nuclear translocation of IRF-3. Further more, LJ reduced the activation of STAT-1, 3 which are involved in continuous secretion of immune cytokines. Blockade of IL-10 action caused a significant reduction of type I IFN and IRF-1, 7 than LPS-induced LJ pretreatment. Conclusions: LJ inhibits LPS-induced production of type I IFN by IL-10. This study may provide a clinical basis for anti-inflammatory properties of LJ.
Keywords
Lonicera japonica; Type I interferon(IFN); Interleukin-10(IL-10); Interferon regulatory factor(IRF); Signal transducers and activators of transcription(STAT);
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Mamane Y, et al. Interferon regulatory factors: the next generation. Gene. 1999;237:1-14.   DOI   ScienceOn
2 Takaoka A, et al. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 2005;434:43-49.
3 Miyamoto M, et al. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements. Cell. 1988;54:903-913.   DOI   ScienceOn
4 Barnes BJ, et al. Virus-specific activation of novel interferon regulatory factor, IRF-5, result in the induction of distinct interferon alpha genes. J Biol Chem. 2001;276(26):23382-23390.   DOI   ScienceOn
5 Barnes BJ, et al. Virus-induced heterodimer formation between IRF-5 and IRF-7 modulates assembly of the IFN enhanceosome in vivo and transcriptional activity of IFN-$\alpha$ genes. J Biol Chem. 2003;278:16630-16641.   DOI   ScienceOn
6 Servant MJ, et al. Overlapping and distinct mechanisms regulating IRF-3 and IRF-7 function. J Interferon Cytokine Res. 2002;22:49-58.   DOI   ScienceOn
7 Fiorentino DF, et al. Two type of mouse helper T cell. Ⅳ. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med. 1989;170:2081-2095.   DOI   ScienceOn
8 Fiorentino DF, et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol. 1991;146:3444-3451.
9 Berkaman, et al. Inhibition of induced expression of macrophage inflammatory protein-1a in human blood monocytes and alveolar macrophages by interleukin-10. J Immunol. 1995;155:4412-4418.
10 김진호. 금은화 물 추출물이 Cerulein 으로 誘發된 白鼠의 급성 췌장염에 미치는 영향. 동신대학교 대학원 박사학위논문집. 2009.
11 이창건 등. 금은화가 LPS로 유발된 급성 폐 손상에 미치는 영향. 대한예방한의학회지. 2011;15(4):49-69.
12 윤경진, 이은용. 금은화 추출액이 RAW 264.7 Macrophage에서의 NO와 PGE2 생성에 미치는 영향. 대한침구학회지. 2012;29(1):67-74.
13 서윤정. 오미소독음의 항염효과 및 기전에 관한 실험적 연구. 대한한방부인과학회지. 2008;21(1):39-54.
14 염병수, 김영판. 방제의 체계적 구성을 위한 임상배합본초학. 서울:영림사. 1994:230-231.
15 김형균 등. 한약의 약리. 서울:고려의학. 2000:335-336.
16 Han DS, et al. Development of anticancer agents from korean medical plants. part 6, cytoxid activity of the ethyl acetate soluble fraction of Lonicera Flos against human oral epitheloid carcinoma cells. Korean J Pharmacogn. 1998;29(1):22-27.
17 Son KH, et al. Flavonoids from aerial parts of Lonicera japonica. Arch Pharmacol Res. 1992;15:365-370.   DOI
18 Lee SJ, et al. Anti-inflammatory activity of the major constituents of Lonicera japonica. Arch Pharm Res. 1995;18(2):133-135.   DOI
19 동의보감국역위원회. 국역증보동의보감. 서울:남산당. 1995:508, 537, 538, 540.
20 김상찬 등. 방제학. 서울:영림사. 1999 :83-84.
21 Matsuda H, et al. Structural reqirements of flavonoid for nitric oxide production inhibitory activity and mechanism of action. Bioorganic Med Chem. 2003; 11:1995-2000.   DOI   ScienceOn
22 Calixto JB, et al. Anti-inflammatory compounds of plant origin. Part II. modulation of pro-inflammatory cytokines, chemokines and adhesion molecules. Planta Med. 2004;70(2) :93-103.   DOI   ScienceOn
23 Cabuk M, et al. Arthritis induced by interferon-alpha therapy in a patient with essential thrombocythemia. Leukmia and Lymphoma. 2003;44(2):377-378.   DOI
24 Mege JL, et al. The two faces of interleukin 10 in human infectious diseases. The Lancet infectious diseases. 2006;6:557-569.   DOI   ScienceOn
25 Nieworld TB, Gibofsky A. Concomitant interferon-alpha therapy and tumor necrosis factor alpha inhibition for rheumatoid arthritis and hepatitis C. Arthritis Rheum. 2006;54:2335-2337.   DOI   ScienceOn
26 Banchereau J, Pascual V. Type Ⅰ interferon in systemic lupus erythematosus and other autoimmune disease. Immunity. 2006;25:383-392.   DOI   ScienceOn
27 Moore KW, et al. Interleukin-10 and the interleukin-10 and the interleukin-10 recepter. Annual review of immunology. 2001;19:683-765.   DOI   ScienceOn
28 전국한의과대학본초학교수 공편. 본초학. 서울:영림사. 2004:198-199.
29 김동현 등. 한방약리학. 서울:신일상사. 2006:133-135.
30 이상철. LPS 유도 생쥐 관절염에서 금은화의 MIF 활성 조절이 COX-2 와 MMP-9 생성 억제에 미치는 영향. 동국대학교 대학원 석사학위논문집. 2009.
31 채기원. 금은화의 항염작용과 파골세포 형성 억제효과. 경희대학교 대학원 박사학위논문집. 2008.
32 윤용갑 등. 금은화 수용성 추출물의 LPS 유도 염증매개물 억제 효과. 대한본초학회지. 2007;22(3):117-125.
33 Kang OH, et al. Inhibition of trypsin -induced mast cell activation by water fraction of flowers of Lonicera japonica. Archives of pharmacal research. 2004;27(11):1141-1146.   DOI   ScienceOn
34 배지현 등. 식중독 유발세균의 증식에 미치는 금은화 추출물의 항균효과. 한국식품과학회지. 2005;37(4):642-647.
35 박희수. 금은화 약침의 항암효과에 관한 연구. 대한침구학회지. 2005;22(5) :91-97.
36 한재섭, 박희수. 금은화약침의 항암 및 면역반응에 관한 실험적 연구. 대한침구학회지. 2006;23(4):205-218.
37 이동언. 金銀花 및 金銀花全草가 Raw 264.7 cell에서 LPS로 유도된 NO의 생성, iNOS, COX-2 및 cytokine에 미치는 영향. 대구한의대학교 대학원 박사학위논문집. 2005.
38 Honda K, et al. Type I Interferon Gene Induction by the Interferon Regulatory Factor Family of Transcription Factors. Immunity. 2006;25:349-360.   DOI   ScienceOn
39 Chawla-Sarkar M, et al. Apoptosis and interferons: role of interferonstimulated genes as mediators of apoptosis. Apoptosis. 2003;8:237-249.   DOI   ScienceOn
40 Pestka S, et al. Interferons, interferon -like cytokines, and their receptors. Immunol Rev. 2004;202:8-32.   DOI   ScienceOn
41 Bogdan C. The function of type I Interferons in antimicrobial immunity. Curr Opin Immunol. 2000;12(4):419-424.   DOI   ScienceOn
42 Taniguchi T, et al. IRF Family of transcription factors as regulators of host defense. Annu Rev Immunol. 2001;19:623-655.   DOI   ScienceOn
43 Colonna M. TLR pathways and IFN -regulatory factors: To each its own. Eur J Immunol. 2007;37:306-309.   DOI   ScienceOn
44 Baccala R, et al. TLR-dependent and TLR-independent pathways of type I interferon induced in systemic autoimmunity. Nature Med. 2007;13(5) :543-551.   DOI   ScienceOn
45 Karaghiosoff M, et al. Central role for type I Interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock. Nat Immunol. 2003;4(5):471-477.   DOI   ScienceOn
46 Servera M, Fitzgerald KA. TLRmediated activation of type I IFN during antiviral responses. Current topics in microbiology and immunology. 2007;316:167-192.
47 Marie I, et al. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J. 1998; 17(22):6660-6669.   DOI   ScienceOn
48 대한병리학회. 병리학. 서울:고문사. 1997 :65-66.
49 Sato M, et al. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity. 2000;13(4):539-548.   DOI   ScienceOn
50 Abul K, Abbas AK. Cellular and Molecular Immunology. 6th edition. philadelphia:Saunders Elsevier. 2006 :75-97.
51 Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cellular Signal. 2001;13:85-94.   DOI   ScienceOn
52 Kubes P, Mccafferty DM. Nitric oxide and intestinal inflammation. American J Medicine. 2000;109:150-158.   DOI   ScienceOn
53 Rietschel ET, et al. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 1994; 8(2):217-225.
54 Galdiero F, et al. Release of cytokines induced by Salmonella typhimurium porins. Infect Immun. 1993;61(1):155-161.
55 Platanias LC, Fish EN. Signaling pathways activated by interferons. Exp Hematol. 1999;27:1583-1592.   DOI   ScienceOn
56 Sen GC. Viruses and interferons. Annu Rev Microbiol. 2001;55:255-281.   DOI   ScienceOn
57 Biron CA. Interferons alpha and beta as immune regulators - a new look. Immunity. 2001;14(6):661-664.   DOI   ScienceOn
58 De Waal Malefty R, et al. Interleukin (IL-10) and viral IL-10 strongly reduced antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class Ⅱ major histocompatibility complex expression. J Exp Med. 1991;174(4):915-924.   DOI   ScienceOn
59 John M, et al. Expression and release of interleukin-8 by human airway smooth muscle cells: inhibition by Th2 cytokines and corticosteroids. Am J Respir Cell Mol Biol J. 1998;18(1):84-90.   DOI   ScienceOn
60 Cunha FQ, et al. Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages. Biochem Biophys Res Commun. 1992;182:1155-1159.   DOI   ScienceOn
61 정원석 등. 플라보노이드 루테올린의 lipopolysaccharide로 유도한 type Ⅰ interferon 억제효과. 동의생리병리학회지. 2009;23(5):986-992.
62 Schindler C, Darnell JE Jr. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem. 1995;64:621-651.   DOI   ScienceOn
63 Darnell JE Jr. STATs and gene regulation. Science. 1997;277:1630-1635.   DOI   ScienceOn
64 Darnell JE Jr, et al. JAK-STAT Pathways and Transcriptional Activation in Response to IFNs and Other Extracellular Signaling Proteins. Science. 1994;5164:1415-1421.
65 Leonard WJ. Stats and cytokine specificity. Nature Med. 1996;2:968-969.   DOI   ScienceOn
66 Leonard WJ, O'Shea JJ. Jaks and STATs: Biological implications. Annu Rev Immunol. 1998;16:293-322.   DOI   ScienceOn
67 Zhong Z, et al. Stat3: a STAT family member activated by tyrosin phosphorylation in response to epidermal growth factor and interleukin-6. Science. 1994;264:95-98.   DOI
68 Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature. 2000;406(6797):782-787.   DOI   ScienceOn
69 Sadler AJ, Williams BR. Interferon -inducible antiviral effectors. Nat Rev Immunol. 2008;8:559-568.   DOI   ScienceOn